Thought Leaders in Big Data: Pumas.ai CEO Joga Gobburu (Part 4)

Sramana Mitra: Let’s switch to your precision medicine area. Take me through a case study. Joga Gobburu: What we have is an advanced clinical decision support system. This system is integrated and sits within the hospital electronic health records. When a physician diagnoses a patient with a condition and is considering a treatment, let’s say

Read Full Article »

Thought Leaders in Big Data: Pumas.ai CEO Joga Gobburu (Part 3)

Sramana Mitra: Were you able to get that approval? Joga Gobburu: Yes. We got the consensus from the FDA, and they agreed to this preemptive marker. It’s underway already. Sramana Mitra: My next question in the context of this case study is, what is it that you know from the adult trial that can be

Read Full Article »

Thought Leaders in Big Data: Pumas.ai CEO Joga Gobburu (Part 2)

Sramana Mitra: I’d like to explore two directions based on what you said. Have you actually developed a drug using this methodology or have you facilitated drug development for a pharmaceutical? If you’re allowed to talk about that, I want to do a use case of stepping through the whole process. Joga Gobburu: Absolutely.

Thought Leaders in Big Data: Pumas.ai CEO Joga Gobburu (Part 1)

Big Data Analytics and Machine Learning techniques are starting to achieve dramatic impact on drug discovery and precision medicine. Pumas.ai is a bootstrapped venture at the cutting edge of the field. I learned much from this conversation. You will too! Sramana Mitra: Let’s start with an introduction of yourself as well as the company.